Compare the best healthcare stocks, get the most updated comparison by key indicators and discover each stock’s price target as well as recommendations by top Wall Street experts.

Compare up to 7 stocks

Clear

PFE NVS MRK JNJ RHHBY

Comparison Results

PFEPfizer

$33.69

0.2 (0.6%)

$40.13

(19.12% Upside)

187.26B

19.60

5.58%

2Buy

7Hold

0Sell

Hold

NVSNovartis

$87.45

1.54 (1.79%)

$103.80

(18.70% Upside)

197.36B

24.80

1.20%

2Buy

1Hold

1Sell

Moderate Buy

MRKMerck & Company

$72.38

-0.24 (-0.33%)

$93.50

(29.18% Upside)

183.12B

26.20

-7.91%

3Buy

1Hold

0Sell

Strong Buy

JNJJohnson & Johnson

$159.32

0.86 (0.54%)

$189.90

(19.19% Upside)

418.80B

28.80

16.23%

10Buy

1Hold

0Sell

Strong Buy

RHHBYRoche Holding

$40.97

-0.13 (-0.32%)

―

279.62B

17.80

1.71%

1Buy

1Hold

0Sell

Moderate Buy

Performance Comparison

Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.

Healthcare Stocks Latest News

J&J’s Single-Dose COVID-19 Vaccine Cleared For Emergency Use In US

Johnson & Johnson’s single-dose COVID-19 vaccine has been authorized for emergency use by the US Food and Drug...

Sharon WrobelFeb 28, 2021

JNJ

Nektar Posts Better-Than-Feared Quarterly Loss, Misses On Revenues

Nektar Therapeutics reported a better-than-expected loss in the fourth quarter but lagged analysts’ expectations for revenues. Shares of...

Priti RamgarhiaFeb 26, 2021

MRK NKTR MERCK

Merck Inks Deal To Buy Pandion Therapeutics For $1.85B; Shares Skyrocket

Merck & Company agreed to snap up Pandion Therapeutics, a clinical-stage biotechnology company, in a deal worth $1.85...

Priti RamgarhiaFeb 26, 2021

MRK PAND

Pfizer-BioNTech To Supply Another 200M COVID-19 Vaccine Doses To EU

Pfizer Inc and BioNTech SE have inked an agreement to supply 200 million additional doses of their COVID-19...

Shrilekha PetheFeb 17, 2021

PFE BNTX

High Efficacy Of Pfizer’s COVID Vaccine Corroborated By Clalit – Report

Israel’s largest health maintenance organization (HMO), Clalit Health Services Research Institute, has published a research paper that confirms...

Daniel PlaksFeb 15, 2021

PFE

J&J Files For FDA Approval Of COVID-19 Vaccine; Street is Bullish

Johnson & Johnson has submitted an application to the US Food and Drug Administration (FDA) for emergency use...

Sharon WrobelFeb 07, 2021

JNJ

Pfizer Lifts 2021 Guidance On Expectations Of $15B In Covid-19 Vaccine Sales

Pfizer ramped up its 2021 full-year guidance as the US drug maker expects to generate $15 billion from...

Sharon WrobelFeb 02, 2021

PFE

Johnson & Johnson Expects Covid-19 Vaccine Trial Results Out Soon

Johnson & Johnson announced that it is likely to release the Phase 3 trial results of its Covid-19...

Shrilekha PetheJan 27, 2021

JNJ

Merck Stops Covid-19 Vaccine Program Due To Disappointing Data

Merck & Co. has decided to stop the development of its two COVID-19 vaccine candidates following “inferior” immune...

Sharon WrobelJan 25, 2021

MRK

Pfizer-BioNTech’s Covid-19 Vaccine Approved By Australia’s Regulator

Pfizer-BioNTech’s COVID-19 vaccine has been cleared by Australia’s health regulator to be used for immunization in individuals aged...

Sharon WrobelJan 25, 2021

PFE BNTX

Read the latest stock news and analysis from the TipRanks news team.

See All News >

Recent Analysts Ratings of Healthcare Stocks

MRKMerck & Company

Premium

Buy

Premium

Reiterated

2021-02-25

PFEPfizer Inc

Premium

Hold

Premium

Reiterated

2021-02-24

JNJJohnson & Johnson

Premium

Hold

Premium

Reiterated

2021-02-22

NVSNovartis AG

Premium

Hold

Premium

Downgraded

2021-02-01

RHHBYRoche Holding AG

Premium

Hold

Premium

Downgraded

2021-01-08

MRKMerck & Company

Premium

Hold

Premium

Reiterated

2021-02-05

PFEPfizer Inc

Premium

Hold

Premium

Reiterated

2021-02-03

PFEPfizer Inc

Premium

Buy

Premium

Upgraded

2021-02-03

PFEPfizer Inc

Premium

Buy

Premium

Reiterated

2021-02-03

PFEPfizer Inc

Premium

Hold

Premium

Reiterated

2021-02-02

All Ratings >

Most Recent Earnings of Healthcare Stocks

PFEPfizer

Feb 02, 2021

2020 (Q4)

0.54 / 0.10

-0.061

263.93% (+0.16)

NVSNovartis

Jan 26, 2021

2020 (Q4)

1.38 / 0.93

0.499

85.77% (+0.43)

MRKMerck & Company

Feb 04, 2021

2020 (Q4)

1.38 / -0.82

0.921

-189.47% (-1.75)

JNJJohnson & Johnson

Jan 26, 2021

2020 (Q4)

1.83 / 0.65

1.502

-56.66% (-0.85)

RHHBYRoche Holding

Feb 04, 2021

2020 (Q4)

1.24 / 1.00

0.721

38.14% (+0.28)

Healthcare Stocks - FAQ

Which Healthcare stocks have a "Strong Buy" analyst rating?

These Healthcare stocks currently have a "Strong Buy" analyst rating consensus:

Merck & Company - Strong Buy, based on 4 analyst ratings, 3 Buy, 1 Hold, and 0 Sell.

Johnson & Johnson - Strong Buy, based on 11 analyst ratings, 10 Buy, 1 Hold, and 0 Sell.

Are Healthcare stocks overpriced?

Pfizer's stock price is currently $33.69, and its average 12-month price target is $40.13.

Novartis's stock price is currently $87.45, and its average 12-month price target is $103.80.

Merck & Company's stock price is currently $72.38, and its average 12-month price target is $93.50.

Johnson & Johnson's stock price is currently $159.32, and its average 12-month price target is $189.90.

Roche Holding's stock price is currently $40.97, and its average 12-month price target is N/A.

Which Healthcare stocks pay dividends?

Pfizer does not currently pay dividends.

Novartis currently pays a dividend of $2.20 which represents an annual dividend yield of 3.93%. Novartis's next Ex-dividend date is March 4, 2021 and its next payout date is March 15, 2021.

Merck & Company currently pays a dividend of $0.65 which represents an annual dividend yield of 3.58%. Merck & Company's next Ex-dividend date is March 12, 2021 and its next payout date is April 7, 2021.

Johnson & Johnson does not currently pay dividends.

Roche Holding currently pays a dividend of $0.81 which represents an annual dividend yield of 1.97%. Roche Holding's next Ex-dividend date is March 18, 2021 and its next payout date is March 29, 2021.